Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
August 2015

T. gondii, Schizophrenia, and other Psychiatric Disorders
Powerful evidence supports an association between the parasite Toxoplasma gondii and schizophrenia.

Risks of Marijuana
The combination of a large selection of products, poor labeling, and a lack of regulatory oversight in the states that have approved marijuana for recreational use has created a potentially dangerous situation for consumers, who receive little guidance regarding dosing.

Antipsychotics in Dementia: Quantifying the Mortality Risk
Antipsychotics are associated with an increase in mortality risk for patients with dementia. Alternative interventions should be considered first to treat agitation, aggression, and psychosis in this population

In Brief
Schizophrenia Patients with Genetic Mutation Have Equal Response but More Serious Side Effects; Passage of Medical Marijuana Laws Does Not Increase Adolescent Use

Compromised Health in Schizophrenia: Venous Thromboembolism and Fractures
Patients with schizophrenia have an elevated risk of venous thromboembolism and fractures.

Activate Online Access

Please fill out this form as completely as possible in order for us to activate your online access:

* denotes required fields.